Cargando…

Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria

Pegvaliase is approved to reduce phenylalanine (Phe) levels for people with phenylketonuria (PKU). PRISM‐1 (NCT01819727) and PRISM‐2 (NCT01889862) data were analyzed to evaluate the relationship between Phe and inattention in adult participants with PKU. In the modified‐intent‐to‐treat population (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilder, Deborah A., Arnold, Georgianne L., Dimmock, David, Grant, Mitzie L., Janzen, Darren, Longo, Nicola, Nguyen‐Driver, Mina, Jurecki, Elaina, Merilainen, Markus, Amato, Gianni, Waisbren, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299696/ https://www.ncbi.nlm.nih.gov/pubmed/34826353 http://dx.doi.org/10.1002/ajmg.a.62574

Ejemplares similares

Development of the US English version of the phenylketonuria – quality of life (PKU-QOL) questionnaire
por: Jurecki, Elaina, et al.
Publicado: (2017)

A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials
por: Burton, Barbara K., et al.
Publicado: (2021)

Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome
por: Quinn, Jennifer, et al.
Publicado: (2021)

Age-Related Psychophysiological Vulnerability to Phenylalanine in Phenylketonuria
por: Leuzzi, Vincenzo, et al.
Publicado: (2014)

Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria
por: Singh, Virender, et al.
Publicado: (2014)

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria
por: Biglari, Alireza, et al.
Publicado: (2015)

Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria
por: Didycz, Bozena, et al.
Publicado: (2017)

Phenylalanine free infant formula in the dietary management of phenylketonuria
por: Yilmaz, Ozlem, et al.
Publicado: (2023)

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
por: Zori, Roberto, et al.
Publicado: (2019)

Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China
por: Zhou, Yong-An, et al.
Publicado: (2012)

Mutation analysis of Phenylalanine hydroxylase gene in Iranian patients with Phenylketonuria
por: Rastegar Moghadam, Mahsa, et al.
Publicado: (2018)

Comparison of phenylalanine tolerance in singleton and twin pregnancies in patients with phenylketonuria
por: Hozyasz, Kamil Konrad, et al.
Publicado: (2020)

Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance
por: Kreile, M., et al.
Publicado: (2020)

Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria
por: Bilder, Deborah A., et al.
Publicado: (2016)

Complications of the Low Phenylalanine Diet for Patients with Phenylketonuria and the Benefits of Increased Natural Protein
por: McWhorter, Nicole, et al.
Publicado: (2022)

Neuroradiological findings of an adolescent with early treated phenylketonuria: is phenylalanine restriction enough?
por: Beckhauser, Mayara Thays, et al.
Publicado: (2011)

High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
por: ten Hoedt, Amber E., et al.
Publicado: (2010)

Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018)

Preparation of a Selective L-Phenylalanine Imprinted Polymer Implicated in Patients with Phenylketonuria
por: Najafizadeh, Parvaneh, et al.
Publicado: (2014)

Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2020)

Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
por: Zamani, Reza, et al.
Publicado: (2021)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2022)

Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pinto, Alex, et al.
Publicado: (2023)

Propagation of Plasma L-Phenylalanine Concentration Fluctuations to the Neurovascular Unit in Phenylketonuria: An in silico Study
por: Taslimifar, Mehdi, et al.
Publicado: (2019)

The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
por: Zhang, Chuan, et al.
Publicado: (2023)

Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
por: Maler, Victor, et al.
Publicado: (2023)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
por: Diaz-Trelles, Ramon, et al.
Publicado: (2022)

Newborn screening 50 years later: access issues faced by adults with PKU
por: Berry, Susan A., et al.
Publicado: (2013)

Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria
por: De Luigi, Ada, et al.
Publicado: (2015)

The evaluation of phenylalanine levels in Estonian phenylketonuria patients during eight years by electronic laboratory records
por: Lilleväli, Hardo, et al.
Publicado: (2019)

The Impact of Phenylalanine Levels on Cognitive Outcomes in Adults With Phenylketonuria: Effects Across Tasks and Developmental Stages
por: Romani, Cristina, et al.
Publicado: (2017)

Effect of dietary regime on metabolic control in phenylketonuria: Is exact calculation of phenylalanine intake really necessary?
por: Rohde, Carmen, et al.
Publicado: (2015)

Intrinsic property of phenylalanine to trigger protein aggregation and hemolysis has a direct relevance to phenylketonuria
por: Anand, Bibin G., et al.
Publicado: (2017)

Cognitive Outcomes and Relationships with Phenylalanine in Phenylketonuria: A Comparison between Italian and English Adult Samples
por: Romani, Cristina, et al.
Publicado: (2020)

Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls
por: Sailer, Melissa, et al.
Publicado: (2020)

Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria
por: Manek, Rachna, et al.
Publicado: (2021)

Influence of blood phenylalanine level variations on the development of executive functions and social cognition in children with phenylketonuria
por: de Almeida Duarte, Cristiane Mendes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r9hfmtv8dsajssf7655g0la57u